A Real-World Study of Bispecific Antibodies in Multiple Myeloma

Clinical trial NCT06359067 · COMPLETED

Trial details

NCT number: NCT06359067
Sponsor: Assistance Publique - Hôpitaux de Paris
Status: COMPLETED
Study type: OBSERVATIONAL

Multiple Myeloma

Start date: 2022-07-01
Primary completion: 2023-12-31
Enrollment: 600

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.